Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002042266-25-000003
Filing Date
2025-12-11
Accepted
2025-12-11 17:35:47
Documents
1
Period of Report
2025-12-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5825
  Complete submission text file 0002042266-25-000003.txt   8376
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713 248-681-9815
Opus Genetics, Inc. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 223 S. WEST STREET, SUITE 900 RALEIGH NC 27603
Business Address 223 S. WEST STREET, SUITE 900 RALEIGH NC 27603 800-683-5555
Foundation Fighting Blindness Retinal Degeneration Fund (Reporting) CIK: 0002042266 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 251565928

Mailing Address 6925 OAKLAND MILLS ROAD, #701 COLUMBIA MD 21045
Business Address 6925 OAKLAND MILLS ROAD, #701 COLUMBIA MD 21045 800-683-5555
Foundation Fighting Blindness, Inc. (Reporting) CIK: 0002042532 (see all company filings)

State of Incorp.: MD | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 251565927